{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:51:33Z","timestamp":1791420693223,"version":"4.3.3"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T00:00:00Z","timestamp":1783728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"vor","delay-in-days":89,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["Ricerca Corrente"],"award-info":[{"award-number":["Ricerca Corrente"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"DOI":"10.1186\/s13195-026-02142-0","type":"journal-article","created":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T13:54:55Z","timestamp":1783778095000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Analytical and clinical validation of a novel proximity extension assay-based plasma biomarker panel in a cohort of prevalent neurodegenerative dementias"],"prefix":"10.1186","volume":"18","author":[{"given":"Giuseppe Mario","family":"Bentivenga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Mammana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Baiardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Vittoriosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Mastrangelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo","family":"Ruggeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia Marina","family":"Vargiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Polischi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelangelo","family":"Stanzani-Maserati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Rizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Pantieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Raggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabina","family":"Capellari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9444-9524","authenticated-orcid":false,"given":"Piero","family":"Parchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,11]]},"reference":[{"key":"2142_CR1","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1001\/jamaneurol.2025.4470","volume":"1","author":"JP Ney","year":"2026","unstructured":"Ney JP, Steinmetz JD, Anderson-benge E, Gillespie CW, Becker A, Steele X, et al. US Burden of Disorders Affecting the Nervous System: From the Global Burden of Disease 2021 Study. JAMA Neurol. 2026;1:20\u201334.","journal-title":"JAMA Neurol"},{"key":"2142_CR2","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/S0140-6736(25)01294-2","volume":"406","author":"GB Frisoni","year":"2025","unstructured":"Frisoni GB, Hansson O, Nichols E, Garibotto V, Schindler SE, van der Flier WM, et al. New landscape of the diagnosis of Alzheimer\u2019s disease. Lancet. 2025;406:1389\u2013407.","journal-title":"Lancet"},{"key":"2142_CR3","doi-asserted-by":"publisher","first-page":"e14458","DOI":"10.1002\/alz.14458","volume":"21","author":"M Khalafi","year":"2024","unstructured":"Khalafi M, Dartora WJ, McIntire LBJ, Butler TA, Wartchow KM, Hojjati SH, et al. Diagnostic accuracy of phosphorylated tau217 in detecting Alzheimer\u2019s disease pathology among cognitively impaired and unimpaired: A systematic review and meta-analysis. Alzheimers Dement. 2024;21:e14458.","journal-title":"Alzheimers Dement"},{"key":"2142_CR4","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/S1474-4422(25)00227-3","volume":"24","author":"J Therriault","year":"2025","unstructured":"Therriault J, Brum WS, Trudel L, Macedo AC, Bitencourt FV, Martins-Pfeifer CC, et al. Blood phosphorylated tau for the diagnosis of Alzheimer\u2019s disease: a systematic review and meta-analysis. Lancet Neurol. 2025;24:740\u201352.","journal-title":"Lancet Neurol"},{"key":"2142_CR5","doi-asserted-by":"publisher","first-page":"102485","DOI":"10.1016\/j.arr.2024.102485","volume":"101","author":"Y Zou","year":"2024","unstructured":"Zou Y, Wang Y, Ma X, Mu D, Zhong J, Ma C, et al. CSF and blood glial fibrillary acidic protein for the diagnosis of Alzheimer\u2019s disease: A systematic review and meta-analysis. Ageing Res Rev. 2024;101:102485.","journal-title":"Ageing Res Rev"},{"key":"2142_CR6","doi-asserted-by":"publisher","first-page":"3400","DOI":"10.1038\/s41467-021-23620-z","volume":"12","author":"NJ Ashton","year":"2021","unstructured":"Ashton NJ, Janelidze S, Al Khleifat A, Leuzy A, van der Ende EL, Karikari TK, et al. A multicentre validation study of the diagnostic value of plasma neurofilament light. Nat Commun. 2021;12:3400.","journal-title":"Nat Commun"},{"key":"2142_CR7","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s13195-022-01093-6","volume":"14","author":"S Baiardi","year":"2022","unstructured":"Baiardi S, Quadalti C, Mammana A, Dellavalle S, Zenesini C, Sambati L, et al. Diagnostic value of plasma p-tau181, NfL, and GFAP in a clinical setting cohort of prevalent neurodegenerative dementias. Alzheimers Res Ther. 2022;14:153.","journal-title":"Alzheimers Res Ther"},{"key":"2142_CR8","doi-asserted-by":"crossref","unstructured":"Doecke JD, Bellomo G, Vermunt L, Alcolea D, Halbgebauer S et al. In \u2019t Veld S,. Diagnostic performance of plasma A\u03b242\/40 ratio, p-tau181, GFAP, and NfL along the continuum of Alzheimer\u2019s disease and non-AD dementias: An international multi-center study. Alzheimers Dement. 2025;21:e14573.","DOI":"10.1002\/alz.14573"},{"key":"2142_CR9","doi-asserted-by":"publisher","first-page":"5635","DOI":"10.1038\/s41467-023-41122-y","volume":"14","author":"M del Campo","year":"2023","unstructured":"del Campo M, Vermunt L, Peeters CFW, Sieben A, Hok-A-Hin YS, Lle\u00f3 A, et al. CSF proteome profiling reveals biomarkers to discriminate dementia with Lewy bodies from Alzheimer\u00b4s disease. Nat Commun. 2023;14:5635.","journal-title":"Nat Commun"},{"key":"2142_CR10","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s13024-025-00882-5","volume":"20","author":"YS Hok-A-Hin","year":"2025","unstructured":"Hok-A-Hin YS, Vermunt L, Peeters CFW, van der Ende EL, de Boer SCM, Meeter LH, et al. Large-scale CSF proteome profiling identifies biomarkers for accurate diagnosis of frontotemporal dementia. Mol Neurodegener. 2025;20:93.","journal-title":"Mol Neurodegener"},{"key":"2142_CR11","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1038\/s43587-022-00300-1","volume":"2","author":"M del Campo","year":"2022","unstructured":"del Campo M, Peeters CF, Johnson ECB, Vermunt L, Hok-A-Hin YS, van Nee M, et al. CSF proteome profiling reveals protein panels reflecting the pathophysiological diversity of Alzheimer\u2019s disease. Nat Aging. 2022;2:1040\u201353.","journal-title":"Nat Aging"},{"key":"2142_CR12","unstructured":"Olink\u00ae. Olink\u00ae \u2014 Part of Thermo Fisher Scientific. https:\/\/olink.com.\u00a0Accessed 01 February 2026."},{"key":"2142_CR13","doi-asserted-by":"publisher","first-page":"5143","DOI":"10.1002\/alz.13859","volume":"20","author":"CR Jack Jr","year":"2024","unstructured":"Jack CR Jr, Andrews JS, Beach TG, Buracchio T, Dunn B, Graf A, et al. Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s Association Workgroup. Alzheimers Dement. 2024;20:5143\u201369.","journal-title":"Alzheimers Dement"},{"key":"2142_CR14","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","volume":"89","author":"IG McKeith","year":"2017","unstructured":"McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor J-P, Weintraub D, et al. Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium. Neurology. 2017;89:88\u2013100.","journal-title":"Neurology"},{"key":"2142_CR15","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1212\/WNL.0000000000009323","volume":"94","author":"IG McKeith","year":"2020","unstructured":"McKeith IG, Ferman TJ, Thomas AJ, Blanc F, Boeve BF, Fujishiro H, et al. Research criteria for the diagnosis of prodromal dementia with Lewy bodies. Neurology. 2020;94:743\u201355.","journal-title":"Neurology"},{"key":"2142_CR16","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1093\/brain\/awr179","volume":"134","author":"K Rascovsky","year":"2011","unstructured":"Rascovsky K, Hodges JR, Knopman D, Mendez MF, Kramer JH, Neuhaus J, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain. 2011;134:2456\u201377.","journal-title":"Brain"},{"key":"2142_CR17","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1212\/WNL.0b013e31821103e6","volume":"76","author":"ML Gorno-Tempini","year":"2011","unstructured":"Gorno-Tempini ML, Hillis AE, Weintraub S, Kertesz A, Mendez M, Cappa SF, et al. Classification of primary progressive aphasia and its variants. Neurology. 2011;76:1006\u201314.","journal-title":"Neurology"},{"key":"2142_CR18","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1002\/mds.26987","volume":"32","author":"GU H\u00f6glinger","year":"2017","unstructured":"H\u00f6glinger GU, Respondek G, Stamelou M, Kurz C, Josephs KA, Lang AE, et al. Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria: MDS Clinical Diagnostic Criteria for PSP. Mov Disord. 2017;32:853\u201364.","journal-title":"Mov Disord"},{"key":"2142_CR19","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1212\/WNL.0b013e31827f0fd1","volume":"80","author":"MJ Armstrong","year":"2013","unstructured":"Armstrong MJ, Litvan I, Lang AE, Bak TH, Bhatia KP, Borroni B, et al. Criteria for the diagnosis of corticobasal degeneration. Neurology. 2013;80:496\u2013503.","journal-title":"Neurology"},{"key":"2142_CR20","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/S1474-4422(20)30440-3","volume":"20","author":"J Graff-Radford","year":"2021","unstructured":"Graff-Radford J, Yong KXX, Apostolova LG, Bouwman FH, Carrillo M, Dickerson BC, et al. New Insights into Atypical Alzheimer\u2019s Disease in the Era of Biomarkers. Lancet Neurol. 2021;20:222\u201334.","journal-title":"Lancet Neurol"},{"key":"2142_CR21","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s00401-023-02663-0","volume":"147","author":"GM Bentivenga","year":"2024","unstructured":"Bentivenga GM, Mammana A, Baiardi S, Rossi M, Ticca A, Magliocchetti F, et al. Performance of a seed amplification assay for misfolded alpha-synuclein in cerebrospinal fluid and brain tissue in relation to Lewy body disease stage and pathology burden. Acta Neuropathol. 2024;147:18.","journal-title":"Acta Neuropathol"},{"key":"2142_CR22","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1016\/0140-6736(91)92823-K","volume":"337","author":"PR Wenham","year":"1991","unstructured":"Wenham PR, Price WH, Blandell G. Apolipoprotein E genotyping by one-stage PCR. Lancet. 1991;337:1158\u20139.","journal-title":"Lancet"},{"key":"2142_CR23","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s13195-024-01565-x","volume":"16","author":"GM Bentivenga","year":"2024","unstructured":"Bentivenga GM, Baiardi S, Mastrangelo A, Ruggeri E, Mammana A, Ticca A, et al. Clinical, neuropathological, and molecular characteristics of rapidly progressive dementia with Lewy bodies: a distinct clinicopathological entity? Alzheimers Res Ther. 2024;16:201.","journal-title":"Alzheimers Res Ther"},{"key":"2142_CR24","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/s41586-020-2649-2","volume":"585","author":"CR Harris","year":"2020","unstructured":"Harris CR, Millman KJ, Van Der Walt SJ, Gommers R, Virtanen P, Cournapeau D, et al. Array programming with NumPy. Nature. 2020;585:357\u201362.","journal-title":"Nature"},{"key":"2142_CR25","doi-asserted-by":"publisher","unstructured":"The pandas development team. Pandas-dev\/pandas: Pandas (v2.2.2). Zenodo; 2024. https:\/\/doi.org\/10.5281\/zenodo.10957263.","DOI":"10.5281\/zenodo.10957263"},{"key":"2142_CR26","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/s41592-019-0686-2","volume":"17","author":"P Virtanen","year":"2020","unstructured":"Virtanen P, Gommers R, Oliphant TE, Haberland M, Reddy T, Cournapeau D, et al. SciPy 1.0: fundamental algorithms for scientific computing in Python. Nat Methods. 2020;17:261\u201372.","journal-title":"Nat Methods"},{"key":"2142_CR27","doi-asserted-by":"crossref","unstructured":"Seabold S, Perktold J, Statsmodels. Econometric and Statistical Modeling with Python. In: Proceedings of the 9th Python in Science Conference; 2010. p. 92\u20136.","DOI":"10.25080\/Majora-92bf1922-011"},{"key":"2142_CR28","first-page":"2825","volume":"12","author":"F Pedregosa","year":"2011","unstructured":"Pedregosa F, Varoquaux G, Gramfort A, Michel V, Thirion B, Grisel O, et al. Scikit-learn: Machine learning in Python. J Mach Learn Res. 2011;12:2825\u201330.","journal-title":"J Mach Learn Res"},{"key":"2142_CR29","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1109\/MCSE.2007.55","volume":"9","author":"JD Hunter","year":"2007","unstructured":"Hunter JD, Matplotlib. A 2D Graphics Environment. Comput Sci Eng. 2007;9:90\u20135.","journal-title":"Comput Sci Eng"},{"issue":"60","key":"2142_CR30","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.21105\/joss.03021","volume":"6","author":"ML Waskom","year":"2021","unstructured":"Waskom ML. Seaborn: statistical data visualization. J Open Source Softw. 2021;6(60):3021.","journal-title":"J Open Source Softw"},{"key":"2142_CR31","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1001\/jamaneurol.2023.5319","volume":"81","author":"NJ Ashton","year":"2024","unstructured":"Ashton NJ, Brum WS, Di Molfetta G, Benedet AL, Arslan B, Jonaitis E, et al. Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease Pathology. JAMA Neurol. 2024;81:255\u201363.","journal-title":"JAMA Neurol"},{"key":"2142_CR32","doi-asserted-by":"publisher","first-page":"e213769","DOI":"10.1212\/WNL.0000000000213769","volume":"105","author":"J Selma-Gonzalez","year":"2025","unstructured":"Selma-Gonzalez J, Rubio-Guerra S, Garc\u00eda-Castro J, Vera-Campuzano E, Sala I, S\u00e1nchez-Saudin\u00f3s MB, et al. Association of Plasma Phosphorylated Tau 217 With Clinical Deterioration Across Alzheimer Disease Stages. Neurology. 2025;105:e213769.","journal-title":"Neurology"},{"key":"2142_CR33","doi-asserted-by":"publisher","first-page":"e214351","DOI":"10.1212\/WNL.0000000000214351","volume":"106","author":"P Kivis\u00e4kk","year":"2026","unstructured":"Kivis\u00e4kk P, Fatima H, Wu C-Y, Padmanabhan N, Romero D, Gorham T, et al. Postmortem Associations Between Alzheimer Disease Pathology and Plasma pTau217, GFAP, and NfL in AD and AD-Related Dementias. Neurology. 2026;106:e214351.","journal-title":"Neurology"},{"key":"2142_CR34","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1093\/brain\/awae035","volume":"147","author":"P S\u00e1nchez-Juan","year":"2024","unstructured":"S\u00e1nchez-Juan P, Valeriano-Lorenzo E, Ruiz-Gonz\u00e1lez A, Pastor AB, Rodrigo Lara H, L\u00f3pez-Gonz\u00e1lez F, et al. Serum GFAP levels correlate with astrocyte reactivity, post-mortem brain atrophy and neurofibrillary tangles. Brain. 2024;147:1667\u201379.","journal-title":"Brain"},{"key":"2142_CR35","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1038\/s41593-024-01737-w","volume":"27","author":"A Pichet Binette","year":"2024","unstructured":"Pichet Binette A, Gaiteri C, Wennstr\u00f6m M, Kumar A, Hristovska I, Spotorno N, et al. Proteomic changes in Alzheimer\u2019s disease associated with progressive A\u03b2 plaque and tau tangle pathologies. Nat Neurosci. 2024;27:1880\u201391.","journal-title":"Nat Neurosci"},{"key":"2142_CR36","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13024-020-00388-2","volume":"15","author":"I van Steenoven","year":"2020","unstructured":"van Steenoven I, Koel-Simmelink MJA, Vergouw LJM, Tijms BM, Piersma SR, Pham TV, et al. Identification of novel cerebrospinal fluid biomarker candidates for dementia with Lewy bodies: a proteomic approach. Mol Neurodegener. 2020;15:36.","journal-title":"Mol Neurodegener"},{"key":"2142_CR37","doi-asserted-by":"publisher","first-page":"e70343","DOI":"10.1002\/alz.70343","volume":"21","author":"C Delaby","year":"2025","unstructured":"Delaby C, Ladang A, Martinez-Yriarte J, Zecca C, Logroscino G, K\u00f6rtvelyessy P, et al. Clinical use and reporting of neurofilament quantification in neurological disorders: A global overview. Alzheimers Dement. 2025;21:e70343.","journal-title":"Alzheimers Dement"},{"key":"2142_CR38","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1038\/s43587-023-00478-y","volume":"3","author":"JB Pereira","year":"2023","unstructured":"Pereira JB, Kumar A, Hall S, Palmqvist S, Stomrud E, Bali D, et al. DOPA decarboxylase is an emerging biomarker for Parkinsonian disorders including preclinical Lewy body disease. Nat Aging. 2023;3:1201\u20139.","journal-title":"Nat Aging"},{"key":"2142_CR39","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1038\/s41467-025-56293-z","volume":"16","author":"K Bolsewig","year":"2025","unstructured":"Bolsewig K, Willemse EAJ, S\u00e1nchez-Juan P, R\u00e1bano A, Mart\u00ednez M, Doecke JD, et al. Increased plasma DOPA decarboxylase levels in Lewy body disorders are driven by dopaminergic treatment. Nat Commun. 2025;16:1139.","journal-title":"Nat Commun"},{"key":"2142_CR40","doi-asserted-by":"publisher","first-page":"10412","DOI":"10.1038\/s41467-025-66728-2","volume":"16","author":"M Valletta","year":"2025","unstructured":"Valletta M, Vetrano DL, Gregorio C, Rizzuto D, Winblad B, Canevelli M, et al. Blood biomarkers of Alzheimer\u2019s disease and progression across different stages of cognitive decline in the community. Nat Commun. 2025;16:10412.","journal-title":"Nat Commun"},{"key":"2142_CR41","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13024-025-00921-1","volume":"21","author":"MR Duggan","year":"2026","unstructured":"Duggan MR, Oh HS-H, Frank P, Gomez GT, Zweibaum D, Cui Y, et al. OMG! A proteomic determinant of neurodegenerative resiliency. Mol Neurodegener. 2026;21:9.","journal-title":"Mol Neurodegener"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-026-02142-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-026-02142-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-026-02142-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:21:39Z","timestamp":1791418899000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13195-026-02142-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,11]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2142"],"URL":"https:\/\/doi.org\/10.1186\/s13195-026-02142-0","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,11]]},"assertion":[{"value":"3 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted according to the revised Declaration of Helsinki and Good Clinical Practice guidelines and approved by the local ethics committee (approval number AVEC:18025, 113\/2018\/OSS\/AUSLBO). Written informed consent was given by study participants or the next of kin.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"224"}}